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A B S T R A C T
Background: There is inconsistency in the literature regarding the nature of hypothalamic-pituitary-adrenal (HPA) axis functionality in post-traumatic stress disorder
(PTSD).
Purpose: The review aimed to investigate HPA axis functionality via the diurnal profile of cortisol as it relates to PTSD.
Methods: The authors conducted a systematic review of the literature from June 2017 – March 2019 in accordance with The PRISMA Statement in the following four
databases: PubMed, MEDLINE, ScienceDirect and PsycINFO with Full Text. The search strategy was limited to articles in English language, published in peer-
reviewed journals within the last decade and human studies. Search terms included “post-traumatic stress disorder” OR “PTSD”, AND “hypothalamic pituitary
adrenal axis” OR “HPA axis” AND “diurnal cortisol” OR “cortisol”. PTSD sufferers of all trauma types, genders and socioeconomic statuses were included provided
there was a “healthy” control group and an inclusion of reporting on inter-group measurements of diurnal cortisol profiles as a portrayal of HPA axis functionality.
Results: A total of 10 studies met the criteria for inclusion in this review. The association between HPA axis functionality and PTSD was evaluated by the mea-
surement of salivary and/or plasma cortisol concentrations. Only two studies demonstrated an association between PTSD and diurnal cortisol when compared with
respective control groups while three studies found no associations. The remaining five studies found partial, mostly negative associations between PTSD and diurnal
cortisol.
Conclusion: Despite some indications of an association between PTSD and dysregulated HPA axis functionality as demonstrated by diurnal cortisol output, the current
review has revealed mixed findings. As such, a complete understanding of HPA axis dysregulation as it relates to PTSD remains unestablished. Given the findings,
further investigation into the relationship between PTSD trauma-exposed and non-PTSD trauma-exposed individuals and diurnal cortisol is warranted.
1. Introduction
Post-Traumatic Stress Disorder (PTSD) is a severe stress-related
condition that may develop after experiencing a traumatic event.
Characterized as an Axis I disorder in the Diagnostic and Statistical
Manual of Mental Disorders, Fifth Edition (American Psychiatric
Association, 2013), PTSD is defined by four symptom clusters: re-ex-
periencing the traumatic event through flashbacks and nightmares,
avoidance of reminders of the traumatic event, negative alterations in
mood and cognition and hyperarousal which may affect sleep quality
and concentration due to a hyper-vigilant state (American Psychiatric
Association, 2013; Furtado and Katzman, 2015). In order to be diag-
nosed with chronic PTSD, these symptoms must lead to functional
impairment, cause severe distress within the individual for at least one
month and must not be due to the effects of medication or other ill-
nesses (American Psychiatric Association, 2013). Given that PTSD is
estimated to have a lifetime prevalence rate between 7 and 12%, it is a
substantial public health concern (Zaba et al., 2015).
Post-traumatic stress disorder places an undeniable burden on the
sufferer, their families and society considering the mental health
stigma, negative social consequences, and substantial annual medical
costs (Daskalakis et al., 2013). Additionally, PTSD is correlated with an
elevated risk for the development of a variety of co-morbid chronic
diseases due to its associated alterations in a number of physiological
mechanisms/systems such as the metabolic, immune/inflammatory and
central nervous systems as well as influencing epigenetic changes
(Perroud et al., 2014). Alterations within the hypothalamic-pituitary-
adrenal (HPA) axis are of particular interest as dysregulation of this
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system has been proposed to accelerate chronic disease progression
within the PTSD population (Miller et al., 2007).
Previous studies propose that cortisol is one of the hormones that
can represent alterations to HPA axis functionality, particularly with
respect to its diurnal rhythm. Typically, the diurnal (i.e. circadian)
rhythm of cortisol follows a 24-h cycle, peaking within an hour of
waking, gradually declining throughout the day and reaching its lowest
point during sleep (Morris et al., 2012; Ryan et al., 2016). From a
measurement perspective, findings of diminished diurnal cortisol se-
cretion may be partly attributed to a dampened cortisol awakening
response (CAR), described as a rapid burst in cortisol output ensuing
post-morning awakening (Clow et al., 2010). Other measurable aspects
include the diurnal cortisol slope (i.e. the characteristic decline in
cortisol from morning to evening) and the area under the curve, which
reflects cumulative cortisol output across the day (Adam and Kumari,
2009; Ryan et al., 2016). Alterations to these parameters, and thus
abnormal diurnal cortisol output, may prevent the body's return to
homeostasis and dysregulated HPA axis functioning. (Daskalakis et al.,
2013; Morris et al., 2012). With respect to dysregulated HPA axis ac-
tivity and the various regulatory roles of cortisol, such alterations to
diurnal cortisol output may have an impact on other physiological
processes such as glucose metabolism, digestion, inflammation and
memory encoding/retrieving (Meewisse et al., 2007; Reul and Nutt,
2008).
However, discrepancies remain regarding HPA axis dysregulation
post-trauma and the consequential nature of cortisol output under
sustained stress (Luo et al., 2012). Several studies have exhibited lower
than normal diurnal cortisol secretion in PTSD participants, specifically
upon awakening and throughout the afternoon whilst opposing findings
have been also been reported, and some studies did not detect sig-
nificant differences between PTSD sufferers and their healthy counter-
parts (Bremner et al., 2007; Clow et al., 2010; Cordero et al., 2017; DE
Kloet et al., 2007; Eckart et al., 2009; Gill et al., 2008; Labonte et al.,
2014; Metzger et al., 2008; Pierce and Pritchard, 2016; Van Liempt
et al., 2013; Wahbeh and Oken, 2013).
Given the extent of inconsistency between research methods and
findings regarding cortisol secretion, this systematic review aimed to
investigate research within the last decade that assessed HPA axis
functionality via the diurnal profile of cortisol as it relates to PTSD.
2. Methods/design
We performed a systematic review in accordance with the estab-
lished guidelines from The Preferred Reporting Items for Systematic
Reviewed and meta-analyses (PRISMA) Statement (Liberati et al., 2009;
Moher et al., 2009).
2.1. Search strategy
An electronic literature search of peer-reviewed journal articles was
conducted from June 2017 – March 2019 using four databases
(PubMed, MEDLINE, ScienceDirect and PsycINFO). Medical subject
headings (MeSH) were considered in the development of the search
terms. The search was limited to human studies published in English
language. Studies prior to 2007 were excluded to ensure that data re-
mained recent. Titles, abstracts and methods were screened by the lead
author for relevance based on the selection criteria (Section 2.3) and all
duplicates were removed. The articles deemed relevant were selected
for further consideration (Fig. 1). The search was further limited to
peer-reviewed original research articles with full text available. Review,
meta-analysis and other types of articles (e.g. author manuscript, letters
to editors) were also excluded. A hand search was undertaken of the
reference lists of relevant articles, and those deemed eligible were in-
cluded with the intent to ensure that all articles relevant to the research
had been captured by the search strategy. The abstracts of the articles
deemed relevant by the lead author (K.S) were then independently
reviewed by a further investigator (A.M) for relevance. If consensus was
not reached, the article was moved on to the next stage for a review of
the full-text. The full-texts of the remaining eligible studies were in-
dependently reviewed by the investigators (K.S and A.M) against the
inclusion and exclusion criteria. Disagreements were discussed until
consensus was reached in all cases.
2.2. Search terminology
The search terms used included: “post-traumatic stress disorder” OR
“PTSD”, AND “hypothalamic pituitary adrenal axis” OR “HPA axis”
AND “diurnal cortisol” OR “cortisol”. These were combined using the
Boolean operators AND as stated above and OR between other terms. A
hand search was undertaken of reference lists with the intent to assure
the quality of chosen articles.
2.3. Selection criteria and data extraction
Studies were eligible for inclusion if the following applied: (1) they
examined trauma leading to PTSD; (2) they examined the association
between PTSD, the HPA axis and diurnal cortisol in adults; (3) studies
must have a correlational or longitudinal design (observational, ran-
domized trials); (4) studies must have a healthy control group; (5) they
took diurnal cortisol measurements; (6) results were presented as
mean ± standard deviation and p values were provided.
All papers identified from the initial electronic search process were
imported into EndNote (version X8.1, Thomson Reuters) where all
duplicates were removed. Upon completion of the title and abstract
reviews, a total of 129 articles were identified for full-text review where
10 were identified as meeting the inclusion criteria. The reasons for
excluding each article were recorded.
2.4. Data analysis
After study selection, criteria were followed to maintain the eva-
luation of the studies within narrow standards. The first and essential
criterion was that all details regarding diurnal cortisol collection should
be verified, with description of instruments, data collection protocol,
and methods.
Data extraction of included studies was organized into a table. This
included the following: author and year of publication; number of
participants; study population, trauma type(s) study design; focus and
outcome of the study; the cortisol measurements taken and statistical
significance of study findings.
2.5. Risk of bias
Two independent reviewers used the Physiotherapy Evidence
Database (PEDro) scale to assess the quality and risk of bias of each of
the studies identified as eligible (see Table 1). The PEDro scale is shown
to have good constructive validity (Macedo et al., 2010). It is an 11-
item scale that is used to assess the quality of the methodology in the
studies (Maher et al., 2003; Verhagen et al., 1998). The PEDro scale
measured/assessed the eligibility criteria, randomisation, allocation
processes, similarity of baseline groups, the blinding process, near
complete data sets obtained for the key outcome, between group sta-
tistics reported and measures of variability were included in the se-
lected studies (Verhagen et al., 1998). Criterion one is used to help
determine the external validity of the study; criterion two through to
nine is designed to help identify whether the study has internal validity;
and criterion ten and eleven assist in determining there is sufficient
statistical information for the results to be interpreted appropriately
(Verhagen et al., 1998). Each of these items was allocated a score in
relation to the study. A point was allocated (as represented by an “X”) if
the study met the specified criterion and a zero was given when the
item did not. This was then used to calculate a total score of bias for the
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Fig. 1. PRISMA Flow Chart Schematic representation of the flow of information during the different phases of the systematic review. Articles were included if they
(1) examined trauma leading to PTSD; (2) examined the association between PTSD, the HPA axis and diurnal cortisol in adults; (3) have a correlational or long-
itudinal design (observational, randomized trials); (4) have a healthy control group; (5) took diurnal cortisol measurements; (6) presented results as mean ±
standard deviation and provided p values.
Table 1
The PEDro scale.
Authors and Date 1 2 3 4 5 6 7 8 9 10 11 Total Risk of bias
Cordero et al. (2017) X 0 0 X 0 0 0 X 0 X X 5/11 2/6 (high)
Pierce and Pritchard (2016) X 0 0 X 0 0 0 X 0 X X 5/11 2/6 (high)
Labonté et al. (2014) X 0 0 X 0 0 0 X 0 X X 5/11 2/6 (high)
Van Liempt et al. (2013) X 0 0 X 0 0 0 X 0 X X 5/11 2/6 (high)
Wahbeh and Oken (2013) X 0 0 X 0 0 0 X 0 X X 5/11 2/6 (high)
Eckart et al. (2009) X 0 0 X 0 0 0 X 0 X X 5/11 2/6 (high)
Metzger et al. (2008) X 0 0 X 0 0 0 X 0 X X 5/11 2/6 (high)
DE Kloet et al. (2007) X 0 0 X 0 0 0 X 0 X X 5/11 2/6 (high)
Gill et al. (2008) X 0 0 X 0 0 0 X 0 X X 5/11 2/6 (high)
Bremner et al. (2007) X 0 0 X 0 0 0 X 0 X X 5/11 2/6 (high)
Criteria: 1. eligibility criteria were specified; 2. subjects were randomly allocated to groups (in a crossover study, subjects were randomly allocated an order in which
treatments were received); 3. allocation was concealed; 4. the groups were similar at baseline regarding the most important prognostic indicators; 5. there was
blinding of all subjects; 6. there was blinding of all therapists who administered the therapy; 7. there was blinding of all assessors who measured at least one key
outcome; 8. measures of at least one key outcome were obtained from more than 85% of the subjects initially allocated to groups; 9. all subjects for whom outcome
measures were available received the treatment or control condition as allocated or, where this was not the case, data for at least one key outcome was analysed by
“intention to treat”; 10. the results of between-group statistical comparisons are reported for at least one key outcome; 11. The study provides both point measures
and measures of variability for at least one key outcome (Verhagen et al., 1998).
Note: X: the study met the specified criterion; 0: the study did not meet the specified criterion.
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study by adding all of the items together. The risk of bias for the studies
was established using the criteria from the PEDro scale summating
items two to four and seven to nine. The six criteria that were used in
the current review i) adequacy of randomization (criterion two); ii)
allocation concealment (criterion three); iii) between-group baseline
comparability (criterion four); iv) blinding of outcome assessors (cri-
terion seven); v) adequate follow-up (more than 85%) (criterion eight),
and; vi) intention to treat analysis (criterion nine). A score of five or six
was considered to have a low risk of bias, three to four a moderate risk,
and two or less a high risk.
3. Results
3.1. Study design, characteristics and risk of bias
The initial searches resulted in a total of 1167 manuscripts.
Following the title, abstract and methods screening as well as removal
of duplicates, the number of articles was reduced to 129. From this, 10
studies met the inclusion criteria (Fig. 1) with all selected studies of a
cross-sectional design. Risk of bias assessment revealed that all studies
demonstrated high risk (Table 1). The studies included in this sys-
tematic review are presented in Table 2 with a description of the studies
(including population, types of trauma, design) according to their focus
investigating HPA axis functionality within PTSD sufferers via their
diurnal cortisol profile, the method used to diagnose PTSD, the way in
which diurnal cortisol levels were collected and the statistical sig-
nificance of the study findings.
The main aim of all included studies was to compare cortisol con-
centrations of PTSD participants with those of their healthy counter-
parts in order to demonstrate whether HPA axis dysregulation is pre-
valent within the PTSD population (Table 2).
3.2. Populations assessed
There was a vast range of trauma sources (Table 2) leading to PTSD
within the selected eight studies including military and combat ex-
posure (DE Kloet et al., 2007, Eckart et al., 2009, Pierce and Pritchard,
2016, Van Liempt et al., 2013, Wahbeh and Oken, 2013); motor vehicle
accidents (Labonte et al., 2014); armed assault (Gill et al., 2008;
Labonte et al., 2014); adulthood physical and sexual abuse (Cordero
et al., 2017; Gill et al., 2008; Labonte et al., 2014); childhood physical
and sexual abuse (Bremner et al., 2007; Cordero et al., 2017; Gill et al.,
2008; Labonte et al., 2014); refugee experiences (Eckart et al., 2009),
unexpected death of a family member or close friend (Gill et al., 2008);
witnessing physical assault or murder of another person (Gill et al.,
2008); other (Labonte et al., 2014). Some studies (n=4) only in-
corporated females (Bremner et al., 2007; Cordero et al., 2017; Gill
et al., 2008; Metzger et al., 2008; Pierce and Pritchard, 2016). Three
studies included only males and one study consisted of both females
and males (DE Kloet et al., 2007; Eckart et al., 2009, Labonte et al.,
2014, Van Liempt et al., 2013; Wahbeh and Oken, 2013).
3.3. Control for confounding factors
Through inclusion and exclusion criteria and statistical analyses, the
reviewed studies controlled for the following confounding factors that
are known to implicate the validity of cortisol concentrations: age
(Bremner et al., 2007; Cordero et al., 2017; DE Kloet et al., 2007; Eckart
et al., 2009; Gill et al., 2008; Labonte et al., 2014; Metzger et al., 2008;
Pierce and Pritchard, 2016; Van Liempt et al., 2013; Wahbeh and Oken,
2013); gender (Bremner et al., 2007; Cordero et al., 2017; DE Kloet
et al., 2007; Eckart et al., 2009; Gill et al., 2008; Labonte et al., 2014;
Metzger et al., 2008; Pierce and Pritchard, 2016; Van Liempt et al.,
2013; Wahbeh and Oken, 2013); ethnicity/race (Cordero et al., 2017;
DE Kloet et al., 2007; Eckart et al., 2009; Gill et al., 2008; Metzger et al.,
2008; Pierce and Pritchard, 2016; Van Liempt et al., 2013; Wahbeh and
Oken, 2013); marital status (Cordero et al., 2017; Eckart et al., 2009;
Gill et al., 2008; Van Liempt et al., 2013; Wahbeh and Oken, 2013);
education (Eckart et al., 2009; Gill et al., 2008; Pierce and Pritchard,
2016, Van Liempt et al., 2013); weight (Bremner et al., 2007, Van
Liempt et al., 2013); BMI (DE Kloet et al., 2007, Eckart et al., 2009, Gill
et al., 2008, Metzger et al., 2008, Van Liempt et al., 2013, Wahbeh and
Oken, 2013); menopausal status (if applicable) (Bremner et al., 2007;
Gill et al., 2008); Major Depressive Disorder (MDD) (Bremner et al.,
2007; DE Kloet et al., 2007; Eckart et al., 2009; Gill et al., 2008;
Metzger et al., 2008; Pierce and Pritchard, 2016; Van Liempt et al.,
2013; Wahbeh and Oken, 2013); psychiatric co-morbidities other than
major depressive disorder (Bremner et al., 2007; Cordero et al., 2017;
DE Kloet et al., 2007; Eckart et al., 2009; Metzger et al., 2008; Pierce
and Pritchard, 2016; Van Liempt et al., 2013; Wahbeh and Oken, 2013);
physical co-morbidities (Cordero et al., 2017; DE Kloet et al., 2007;
Eckart et al., 2009; Gill et al., 2008; Wahbeh and Oken, 2013); per-
ceived stress (Wahbeh and Oken, 2013); medication (Cordero et al.,
2017; Eckart et al., 2009; Gill et al., 2008; Labonte et al., 2014; Metzger
et al., 2008; Pierce and Pritchard, 2016; Van Liempt et al., 2013;
Wahbeh and Oken, 2013); smoking status (Cordero et al., 2017; DE
Kloet et al., 2007; Eckart et al., 2009; Gill et al., 2008; Metzger et al.,
2008; Van Liempt et al., 2013; Wahbeh and Oken, 2013); tobacco use
(Pierce and Pritchard, 2016); alcohol/substance abuse or dependence
(Bremner et al., 2007; Cordero et al., 2017; Eckart et al., 2009; Gill
et al., 2008; Metzger et al., 2008; Van Liempt et al., 2013; Wahbeh and
Oken, 2013); early life trauma (Bremner et al., 2007; Cordero et al.,
2017; Metzger et al., 2008); type of trauma (Bremner et al., 2007;
Cordero et al., 2017; DE Kloet et al., 2007; Eckart et al., 2009; Metzger
et al., 2008; Pierce and Pritchard, 2016; Van Liempt et al., 2013;
Wahbeh and Oken, 2013); trauma history (Eckart et al., 2009; Metzger
et al., 2008; Van Liempt et al., 2013; Wahbeh and Oken, 2013); years
exposed to traumatic conditions (Eckart et al., 2009; Metzger et al.,
2008; Van Liempt et al., 2013; Wahbeh and Oken, 2013); time since
trauma (DE Kloet et al., 2007, Eckart et al., 2009, Metzger et al., 2008,
Pierce and Pritchard, 2016, Van Liempt et al., 2013, Wahbeh and Oken,
2013); sleep duration (Eckart et al., 2009; Van Liempt et al., 2013;
Wahbeh and Oken, 2013); time of awakening (Bremner et al., 2007; DE
Kloet et al., 2007; Eckart et al., 2009; Pierce and Pritchard, 2016; Van
Liempt et al., 2013; Wahbeh and Oken, 2013); sample collection time
(Bremner et al., 2007; DE Kloet et al., 2007; Eckart et al., 2009; Metzger
et al., 2008; Pierce and Pritchard, 2016; Van Liempt et al., 2013;
Wahbeh and Oken, 2013).
3.4. Cortisol collection methods and definitions of abnormal cortisol
concentrations
All selected studies sought to investigate the association between
PTSD and the HPA axis via participants' diurnal cortisol profiles.
However, there were variations between studies in the type of sample
used to extract cortisol from as well as a lack of a clear definition of
abnormal cortisol concentrations in some studies. The majority of stu-
dies (n=7) chose to collect cortisol samples solely through partici-
pants’ saliva (Cordero et al., 2017; Eckart et al., 2009; Gill et al., 2008;
Labonte et al., 2014; Metzger et al., 2008; Pierce and Pritchard, 2016;
Wahbeh and Oken, 2013). Two studies used plasma samples and the
last study measured cortisol in both saliva and plasma samples
(Bremner et al., 2007, DE Kloet et al., 2007; Van Liempt et al., 2013)
(see Table 2).
In regard to clearly defining abnormal cortisol concentrations, seven
studies provided their respective intra- and/or inter-assay coefficients
of variation (10% or lower) (Cordero et al., 2017; Eckart et al., 2009;
Labonte et al., 2014; Metzger et al., 2008; Pierce and Pritchard, 2016;
Van Liempt et al., 2013; Wahbeh and Oken, 2013). Two studies not
only provided coefficients of variation but also incorporated distinct
definitions of abnormal cortisol levels through comparing their intra-
and inter-assay results to either time-dependent reference values or
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“cortisol peaks” representing elevations in cortisol levels that were three
times greater than the coefficient of variation (Bremner et al., 2007, DE
Kloet et al., 2007). The remaining study did not include a definition of
abnormal cortisol concentrations (Gill et al., 2008). Each selected study
tested for statistical significance (p < 0.05) when comparing between-
group cortisol levels.
4. Discussion
Amongst the reviewed studies, PTSD-associated dysregulated HPA
axis functionality was only partially demonstrated. This was evident
since two studies indicated an association between PTSD and diurnal
cortisol, three studies did not demonstrate any associations, and the five
remaining studies observed some, although mostly negative associa-
tions. Given the mixed findings, a definitive conclusion on whether
PTSD is specifically associated with dysregulated HPA axis function as
portrayed by altered diurnal cortisol cannot be determined. However,
the studies that did not demonstrate findings for between-group dif-
ferences, or those that presented circumstantial associations (e.g. at a
specific time of day or following experimental methods such as the
Trier Social Stress Test) in cortisol still recognize the disruptions to HPA
axis functionality that seem to characterize PTSD or suggest alternative
contributors that may be responsible for the proposed HPA axis dys-
regulation (Bremner et al., 2007, DE Kloet et al., 2007, Eckart et al.,
2009, Gill et al., 2008, Labonte et al., 2014, Metzger et al., 2008, Pierce
and Pritchard, 2016, Van Liempt et al., 2013).
4.1. Heterogeneity of included studies
Hypothalamic-pituitary-adrenal axis dysregulation was only asso-
ciated with PTSD in two studies (Cordero et al., 2017; Wahbeh and
Oken, 2013). The remaining studies that found partial associations only
indicated altered diurnal cortisol concentrations in the PTSD-affected
populations at specific timepoints or under experimental manipulation.
Thus, the limitations and heterogeneity between studies must be ad-
dressed. Firstly, there was a lack of uniformity in the method of cortisol
collection (see Table 2). Some studies chose to analyze plasma cortisol
as opposed to salivary cortisol (Bremner et al., 2007, DE Kloet et al.,
2007; Van Liempt et al., 2013). In addition, several different psycho-
logical assessments for PTSD diagnosis were used with varying meth-
odology (e.g. structured interview with a psychologist vs. self-report).
As a result of inconsistent measuring techniques, the between-study
findings are difficult to synthesize which may have contributed to the
overall mixed findings. The time of day during which cortisol samples
were collected also varied immensely (see Table 2). Given that cortisol
levels are highly influenced by time, studies with differing cortisol
collection protocols cannot be compared as they exhibit distinctive
“snapshots” of HPA axis functionality (Ryan et al., 2016; Schumacher
et al., 2018). In addition, only four studies provided reference values for
cortisol levels to support their mention of the coefficient of variation
(Bremner et al., 2007; Cordero et al., 2017, DE Kloet et al., 2007; Van
Liempt et al., 2013). Others only included the coefficient of variation
for cortisol (Eckart et al., 2009; Labonte et al., 2014; Metzger et al.,
2008; Pierce and Pritchard, 2016; Wahbeh and Oken, 2013). The re-
maining study did not incorporate either (Gill et al., 2008). Considering
the methodological differences between studies, direct comparison and
synthesis of results is a challenge due to the disparities in the reliability
and sensitivity of differing experimental collection and assessment
methods as well as external influencing factors (Luo et al., 2012).
Inconsistencies were also apparent between studies and their con-
trol for additional confounding factors suggested to influence diurnal
cortisol production and secretion. These confounders included age,
gender, ethnicity/race, marital status, education, weight, BMI, meno-
pausal status (if applicable), Major Depressive Disorder (MDD), psy-
chiatric co-morbidities other than Major Depressive Disorder (MDD),
physical co-morbidities, perceived stress, medication, smoking status,
tobacco use, alcohol/substance abuse or dependence, early life trauma,
type of trauma, trauma history, years exposed to traumatic conditions,
time since trauma, sleep duration, and time of awakening. Therefore,
possible influence of confounding factors on study results and, thus, the
findings from the current review should be considered (Morris et al.,
2012). Although the studies were unable to control for all confounders
(either statistically via results analysis or through inclusion and exclu-
sion criteria), the current review recognizes the difficulty in achieving
such a task. However, the comparison of results between studies re-
mains questionable since, without complete control over confounding
factors, it is impossible to determine the exact nature of HPA axis
functionality in PTSD sufferers.
4.2. Cortisol levels as they relate to trauma exposure versus PTSD
development
Some findings of hypocortisolism suggest that PTSD development is
associated with lower levels of cortisol secretion. Although, several
investigations found no statistically significant differences in diurnal
cortisol output between the PTSD group and the trauma-exposed con-
trol group, thereby attributing decreased cortisol concentrations to
trauma exposure rather than PTSD per se (DE Kloet et al., 2007, Metzger
et al., 2008; Pierce and Pritchard, 2016, Van Liempt et al., 2013). This
would suggest that similar exposure to trauma across study participants
would dictate analogous findings between groups regardless of PTSD
status.
Well-controlled research on highly traumatized refugees conducted
by Eckart et al. (2009) supported the notion that altered cortisol is due
to trauma exposure, and not PTSD, by reporting results that did not
observe significant intergroup differences in cortisol secretion
(p=0.43). However, it is difficult to extract a conclusion based on
these results due to the strenuous and stressful living conditions that all
participants were experiencing at the time of the study. It is possible
that the constant disadvantaged living conditions may illustrate a
“building block effect” such that, under present stress, those with PTSD
displayed elevated diurnal cortisol output to match that of the healthy
counterparts without PTSD (Steudte et al., 2011). Therefore, while it is
possible that trauma exposure alters HPA axis functionality it remains
difficult to confirm in the absence of a non-trauma-exposed control
group (Metzger et al., 2008).
In addition to trauma exposure, some studies have also proposed
that the number of traumatic events may affect cortisol concentrations
in study participants (Eckart et al., 2009; Johnson et al., 2008; Pierce
and Pritchard, 2016). Contrary to earlier concepts of trauma exposure
being a rare event, it is now believed that the majority of the population
will experience significant trauma (whether it be through actively ex-
periencing the event or via observation of others enduring trauma) at
least once in his or her lifetime (Reul and Nutt, 2008). Previous trau-
matic experiences may increase the chance of further traumatic in-
cidences and even persuade the likelihood of enlisting in the military
wherein further traumatic events are likely to occur (Pierce and
Pritchard, 2016). However, this “building block” effect only seems to be
correlated with PTSD symptom severity rather than the association
between cortisol concentrations and the extent of trauma load (Eckart
et al., 2009).
4.3. Cortisol levels as they relate to PTSD severity
Another potential explanation for altered cortisol levels in in-
dividuals with PTSD may not be the disorder itself but rather the se-
verity of its associated symptoms. These findings were supported by Gill
et al. (2008) by demonstrating that dysregulated HPA axis functioning
via lower morning cortisol levels was specifically correlated with PTSD
hyperarousal symptoms. While the proposal that relates lower levels of
morning cortisol secretion with PTSD symptom severity seems plau-
sible, in order to be applicable to understanding HPA axis functionality
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in PTSD, it must be taken into account the entirety of diurnal cortisol
output in the PTSD population as compared to those without the dis-
order. In a “normal” diurnal cycle of salivary cortisol there is a peak in
concentration approximately 30–45min after awakening, which slowly
tapers off after the first hour (Schumacher et al., 2018). Cortisol levels
then seem to rapidly drop as the day progresses until the next morning
(Lauc et al., 2004). By contrast, PTSD sufferers appear to exhibit “flat”
diurnal cortisol profiles, which show a reduced cortisol awakening re-
sponse (CAR) followed by a slight drop within the first 30min post-
awakening and then a gradual increase in concentration as the day goes
on and are characterized by a lesser drop in levels overnight (Lauc
et al., 2004) (see Fig. 2). One explanation for this flattened diurnal
cortisol profile demonstrated in more severe PTSD cases is the in-
dividual's interpretation of how controllable the stress they are under-
going is (Lauc et al., 2004; Miller et al., 2007). More specifically, when
one feels they are capable of coping with their stressor, they seem to
display a higher CAR perhaps in preparation to actively deal with the
situation, as opposed to someone who feels that their stressor is too
severe to control (as demonstrated in people with PTSD) and conse-
quently withdraws from the situation as illustrated by a decreased CAR
and overall “flat” diurnal cortisol profile (Miller et al., 2007).
Whilst current research supports the finding that individuals with
PTSD exhibit some form of dysregulation within the HPA axis leading to
its chronicity and associated co-morbidities, there is still controversy
over how one develops this dysregulation. The disorder may be the
result of an increased vulnerable predisposition due to genetic and
environmental risk factors occurring prior to a traumatic event which
together may alter HPA axis functionality (Het and Wolf, 2007).
However, others suggest that alterations in physiological mechanisms
and hormones are the result of acquiring the disorder itself (Daskalakis
et al., 2013).
4.4. Limitations and strengths
The limitations and strengths of this review should be considered.
Firstly, there was a paucity of studies that qualified for selection within
this review and, despite meeting the inclusion criteria, all studies were
determined to have a high risk of bias (see Table 1). Specifically, a
“high-risk” assessment may have influenced the resulting associations
(or lack thereof) between PTSD and diurnal cortisol. Studies also had a
cross-sectional design and, as such, prohibited causality. Although the
authors of this review conducted a thorough search of the literature
with specified inclusion criteria, there is a possibility that some studies
were missed. The included studies also demonstrated low comparability
due to a lack of standardization between study design, methodology
and confounding factors which could have affected results. It should
also be noted that the authors would have liked to include some ad-
ditional studies for full review, however, those study results were not
presented as mean ± standard deviation and/or number values de-
monstrating statistical significance were not provided. Upon attempt to
contact the researchers for their results there was no response so, un-
fortunately, some studies had to be excluded.
With respect to other similar reviews and meta-analyses, the current
review demonstrated findings in line with Klaassens et al. (2012) and
Schumacher et al. (2018). Commonalities between these studies and the
current review include mixed findings with a mostly negative associa-
tion for PTSD and cortisol. Furthermore, when significance was de-
monstrated, it was likely in relation to a subgroup, such as a specific
timepoint, before statistical adjustments to confounding factors were
made, or in response to an experimental inclusion (Schumacher et al.,
2018). The findings from this review mostly oppose alternative sug-
gestions for an association between PTSD and cortisol, particularly
hypocortisolism (Morris et al., 2012; Pan et al., 2018). However, the
current review offers a unique perspective on the inconsistencies be-
tween PTSD and cortisol. Specifically, only studies that investigated
diurnal cortisol output were included as were trauma of all types and
timepoints whereas Klaassens et al. (2011) and Schumacher et al.
(2018) included studies prior to 2007, various cortisol measurements
(i.e. those not measuring diurnal rhythm) and Klaassens et al. (2011)
excluded childhood trauma. The exclusion of studies that did not
measure diurnal cortisol output provides a more comparable view of
HPA axis functionality in PTSD sufferers as opposed to one aspect of its
functionality (Ryan et al., 2016; Schumacher et al., 2018). Given the
complexity of the interactions between the physiological systems and
mechanisms and their associated hormones as well as the vast un-
knowns in psychoneuroendocrinology research itself, the selected stu-
dies have established a foundation for HPA axis functionality in PTSD
sufferers as portrayed by their diurnal cortisol profiles (Josephs et al.,
2017).
4.5. Future directions
The findings of the included studies propose that the HPA axis is not
functioning properly in the PTSD population but whether this is asso-
ciated with diurnal cortisol secretion output is not consistently ob-
served. The observed results are mixed and influenced by multiple
Fig. 2. Normal vs. Flat Diurnal Cycle of
Salivary Cortisol
Representative illustration of an example of
normal, “healthy” diurnal salivary cortisol
output as compared with that of “flat”
diurnal salivary cortisol output character-
ized by a reduced CAR, gradual increase
throughout the day and higher levels over-
night, as seen in those suffering from PTSD.
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confounders, with an emphasis placed on trauma exposure (DE Kloet
et al., 2007, Metzger et al., 2008; Pierce and Pritchard, 2016, Van
Liempt et al., 2013). Based on this review, standardization of study
design, methodology and protocol for collecting diurnal cortisol should
be incorporated. Specifically, future investigations should measure the
diurnal rhythm of cortisol for at least two days since this methodology
would provide a more comprehensive characterization of HPA axis
functionality and diurnal cortisol as it relates to PTSD (Ryan et al.,
2016). Furthermore, additional research is needed investigating the
potential association between trauma-exposure (as opposed to PTSD
status) and dysregulated HPA axis functionality given the findings from
the current and similar reviews (Klaassens et al., 2012; Schumacher
et al., 2018).
5. Conclusion
Post-traumatic stress disorder is a severely debilitating disorder af-
fecting a multitude of persons from average civilians to first responders
and military personnel. Its effects, if left untreated, lead to a number of
adverse health outcomes. However, the current systematic review de-
monstrates that there is only partial, mostly negative, associations be-
tween PTSD and HPA axis dysregulation in the context of diurnal cor-
tisol output. Furthermore, the lack of findings that indicated a
difference in diurnal cortisol output between PTSD trauma-exposed and
non-PTSD trauma-exposed participants may suggest an association be-
tween trauma exposure and HPA axis functionality instead. The mixed
findings demonstrated by this review have revealed that a complete
understanding of the relationship between PTSD and HPA axis func-
tionality remains unestablished. Future investigations should firstly
standardize experimental design and methodology with respect to
diurnal cortisol measurements and aim to reduce confounding influ-
ences on diurnal cortisol output.
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